Profile data is unavailable for this security.
About the company
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
- Revenue in SEK (TTM)458.22m
- Net income in SEK48.23m
- Incorporated2004
- Employees89.00
- LocationC Rad ABSjukhusvagen 12KUPPSALA 753 09SwedenSWE
- Phone+46 18666930
- Fax+46 18666930
- Websitehttps://c-rad.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omda AS | 407.73m | 86.39m | 838.32m | 291.00 | 9.60 | 9.81 | 5.41 | 2.06 | 4.27 | 4.27 | 20.44 | 4.18 | 0.5534 | 168.94 | 10.73 | 1,432,536.00 | 12.70 | -4.92 | 16.78 | -6.37 | 92.56 | 90.22 | 22.96 | -9.83 | 1.25 | 2.58 | 0.8487 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| Gentian Diagnostics ASA | 139.10m | -5.71m | 859.80m | 58.00 | -- | 5.81 | 245.55 | 6.18 | -0.3783 | -0.3783 | 9.22 | 9.82 | 0.7646 | 1.85 | 6.35 | 2,452,035.00 | -3.14 | -10.76 | -3.58 | -11.86 | 50.84 | 41.46 | -4.10 | -26.99 | 4.14 | -- | 0.0555 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| Mentice AB | 254.07m | -25.98m | 869.34m | 128.00 | -- | 6.41 | 2,120.34 | 3.42 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| OssDsign AB | 117.72m | -118.39m | 896.51m | 48.00 | -- | 4.00 | -- | 7.62 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | 2,452,500.00 | -39.29 | -37.92 | -43.39 | -43.56 | 77.15 | 68.10 | -100.57 | -203.06 | 5.18 | -36.90 | 0.013 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Nightingale Health Oyj | 42.70m | -211.04m | 959.25m | 81.00 | -- | 1.37 | -- | 22.46 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
| Integrum AB | 104.12m | 4.17m | 960.35m | 36.00 | 232.89 | 6.30 | 151.50 | 9.22 | 0.2199 | 0.2199 | 5.55 | 8.13 | 0.6307 | 0.5919 | 3.80 | 2,892,222.00 | 2.53 | 0.7612 | 2.80 | 0.8818 | 87.65 | 83.87 | 4.01 | 1.28 | 3.32 | -- | 0.043 | -- | 40.19 | 35.91 | 212.14 | -- | 127.10 | -- |
| Paxman AB (publ) | 226.42m | 23.97m | 1.05bn | 94.00 | 43.71 | 7.69 | 24.56 | 4.62 | 1.26 | 1.26 | 11.89 | 7.16 | 1.28 | 2.66 | 6.46 | 2,488,099.00 | 13.59 | -5.08 | 18.38 | -7.76 | 69.47 | 69.38 | 10.59 | -5.07 | 1.76 | -- | 0.1122 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| ADDvise Group AB (publ) | 1.48bn | 110.80m | 1.18bn | 620.00 | 26.52 | 3.71 | 5.27 | 0.8006 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Optomed Oyj | 174.70m | -51.10m | 1.35bn | 114.00 | -- | 5.46 | -- | 7.75 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| Nordhealth As | 430.21m | -130.06m | 1.46bn | 395.00 | -- | 2.65 | -- | 3.40 | -1.69 | -1.69 | 5.56 | 12.51 | 0.3561 | -- | 8.25 | 1,113,561.00 | -10.76 | -- | -12.25 | -- | 85.96 | -- | -30.23 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
| BioPorto A/S | 50.71m | -84.30m | 1.48bn | 27.00 | -- | 20.03 | -- | 29.19 | -0.1501 | -0.1501 | 0.0903 | 0.1099 | 0.4132 | 3.66 | 7.33 | 1,044,452.00 | -68.68 | -71.10 | -100.20 | -96.55 | 68.08 | 63.38 | -166.23 | -239.22 | 2.36 | -- | 0.1354 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| C Rad AB | 458.22m | 48.23m | 1.51bn | 89.00 | 32.13 | 5.33 | 26.27 | 3.30 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Genovis AB | 127.01m | 30.68m | 1.83bn | 36.00 | 59.64 | 8.92 | 44.15 | 14.41 | 0.4686 | 0.4686 | 1.94 | 3.13 | 0.5084 | -- | -- | 3,432,784.00 | 12.28 | 18.56 | 13.37 | 21.45 | 66.09 | 65.51 | 24.15 | 23.88 | -- | -- | 0.2769 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
| Bactiguard Holding AB | 230.51m | -76.04m | 2.19bn | 177.00 | -- | 7.53 | -- | 9.51 | -2.17 | -2.17 | 6.58 | 9.37 | 0.3266 | 3.61 | 7.52 | 1,062,240.00 | -10.77 | -7.56 | -14.93 | -8.81 | 43.80 | 47.91 | -32.99 | -26.28 | 0.5741 | -3.93 | 0.4215 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| Stille AB | 362.16m | 35.58m | 2.19bn | 142.00 | 40.66 | 3.40 | 41.11 | 6.05 | 6.00 | 6.00 | 60.20 | 71.84 | 0.5364 | 1.77 | 7.18 | 3,416,557.00 | 5.27 | 7.03 | 6.35 | 8.19 | 46.76 | 43.93 | 9.82 | 9.85 | 0.9879 | 7.17 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
Data as of Jul 24 2024. Currency figures normalised to C Rad AB's reporting currency: Swedish Krona SEK
19.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Eiffel Investment Group SASas of 30 Jun 2023 | 1.09m | 3.33% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 2023 | 1.09m | 3.30% |
| Deka Investment GmbHas of 30 Apr 2023 | 828.50k | 2.52% |
| Cliens Kapitalf�rvaltning ABas of 28 Jun 2023 | 783.83k | 2.38% |
| Handelsbanken Fonder ABas of 30 Jun 2024 | 707.59k | 2.15% |
| Aktia Bank Plc (Investment Management)as of 28 Jun 2024 | 500.00k | 1.52% |
| Aktia Fondbolag Abas of 28 Jun 2023 | 500.00k | 1.52% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 335.00k | 1.02% |
| Mandarine Gestion SAas of 31 Mar 2023 | 294.99k | 0.90% |
| SEB Investment Management ABas of 28 Jun 2024 | 158.06k | 0.48% |
More ▼
Data from 14 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
